Niagen Bioscience (OCD1) Cash flow

2 Followers

Niagen Bioscience Cash Flow

DE:OCD1's free cash flow for Q2 2026 was $2.68M. For the 2026 fiscal year, DE:OCD1's free cash flow was decreased by $1.20M and operating cash flow was $2.77M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 13.44M	$ 12.11M	$ 7.12M	$ -15.10M	$ -24.16M
Investing Cash Flow	$ -292.00K	$ -143.00K	$ -143.00K	$ -334.00K	$ -409.00K
Financing Cash Flow	$ 6.98M	$ 5.37M	$ -90.00K	$ 7.65M	$ 36.09M
End Cash Position	$ 64.79M	$ 44.66M	$ 27.32M	$ 20.44M	$ 28.22M
Free Cash Flow	$ 13.14M	$ 11.95M	$ 6.97M	$ -15.43M	$ -24.57M

Currency in USD